Message From President

Dear Esteemed Members and Friends,

I am incredibly honored and humbled to address you as the newly elected President of the Hong Kong Society of Transcatheter Endo-cardiovascular Therapeutics (HKSTENT). It is with great pride that I assume this esteemed position, following in the footsteps of past presidents who have tirelessly dedicated their time and efforts to the advancement of our society.

First and foremost, I would like to express my heartfelt gratitude to the past presidents of our society. Their visionary leadership and tireless efforts have paved the way for our success and growth. I am grateful for their guidance and invaluable contributions, which have established our society as a prominent force in the field of interventional cardiology.

The Hong Kong Society of Transcatheter Endo-cardiovascular Therapeutics (HKSTENT) was founded in 2010 and holds the distinction of being the first cardiology society in Hong Kong dedicated exclusively to interventional cardiology. Since its inception, our society has been driven by a crucial mission - to promote education, training and research in interventional cardiology in Hong Kong.

During the past decade, we have made remarkable strides in achieving our mission. We have developed a vibrant academic and educational platform, engaging our members in the latest advancements and techniques in the field of endocardiovascular therapeutics. Our society organizes symposiums and courses that focus on various complex interventions, including chronic total occlusion, bifurcation lesions, and more. Through these events, we aim to enhance the knowledge and skills of our members, ensuring that they remain at the forefront of interventional cardiology practice.

One of the highlights of our society's annual calendar is the Cardiovascular Intervention Complication Forum (CICF). This signature event gathers renowned experts from around the world to discuss and address the challenges and complications encountered in interventional cardiology procedures. The CICF provides a unique platform for exchange, collaboration, and the dissemination of ideas among professionals in the field.

As the new President, I am wholeheartedly committed to continuing these important activities and promoting their growth even further. I firmly believe in the power of collaboration and wish to build strong relationships with other international cardiology societies. By fostering these collaboration and partnerships, we can collectively push the boundaries of interventional cardiology, bringing groundbreaking therapies and advancements to our patients.

I would like to express my sincere appreciation to all our members for their unwavering support. Your commitment and active involvement have been fundamental to our society's success. The collaboration and camaraderie we share as members are what truly sets us apart. Let us continue to work together, fostering excellence in interventional cardiology and making a lasting impact on patient care in Hong Kong and beyond.

In closing, I am both honored and humbled to serve as your new President and to lead this prestigious society. I extend my deepest gratitude to our past presidents for their exemplary leadership and tireless efforts. I also express my heartfelt appreciation to our members for your unwavering support. Together, let us seize the opportunities that lie ahead, embrace both local collaboration and global partnerships, and strive for excellence in endocardiovascular therapeutics.

With heartfelt thanks and warm regards,

Dr. Kin-Lam Tsui

President, Hong Kong Society of Transcatheter Endo-cardiovascular Therapeutics (HKSTENT)